ClearCut Medical

Company Overview

Snapshot

Founded in April 2010 by Erez Golan and Eyal Kolka, ClearCut Medical operates with 11–50 employees. The company has raised $707.07K across two funding rounds from two investors. In March 2018, the Australian Department of Health's Therapeutic Goods Administration (TGA) issued a Therapeutic Goods Certificate for its ClearSight MRI System, enabling distribution in Australia.

Business overview

ClearCut Medical develops and commercializes solutions for accurate and effective cancer removal, leveraging magnetic resonance imaging (MRI) protocols for real-time margin assessment of excised tissue in the operating room. Its ClearSight MRI System is specifically designed for breast cancer lumpectomies to improve surgical outcomes and reduce re-excision rates. The company targets the oncology market, with future applications planned for prostate and breast cancer biopsies, skin cancer excisions, and other oncological areas including colorectal and lung cancers. Operating within the Health Tech & Life Sciences sector, ClearCut Medical serves hospitals and surgeons in markets such as the U.S., Europe, and Australia.

Strategic signal

In July 2019, ClearCut Medical appointed Jim Buck as its President & CEO. This leadership change signals a strategic move to potentially drive new growth initiatives and commercialization efforts for its ClearSight MRI System, particularly as the company expands its market presence and aims to improve surgical outcomes in oncology.

Company Intelligence Q&A

What is ClearCut Medical's primary product?

ClearCut Medical's primary product is the ClearSight MRI System, a portable MRI system designed for real-time margin assessment of excised tissue during surgical procedures, initially focused on breast cancer lumpectomies.

When was ClearCut Medical founded and by whom?

ClearCut Medical was founded in April 2010 by Erez Golan and Eyal Kolka.

What significant regulatory approval did ClearCut Medical receive in Australia?

In March 2018, ClearCut Medical received a Therapeutic Goods Certificate from the Australian Department of Health's Therapeutic Goods Administration (TGA) for its ClearSight MRI System, facilitating its supply to surgical cancer centers in Australia through Surgeon Choice Australia Pty Ltd.

Who was appointed as President & CEO of ClearCut Medical?

In July 2019, ClearCut Medical appointed Jim Buck as its President & CEO.

What is the total capital raised by ClearCut Medical?

ClearCut Medical has raised a total of $707.07K across two funding rounds.